The impact of primary diseases is substantial, demanding fresh therapeutic options. Regenerative therapies represent a particularly exciting avenue, offering the potential to regenerate damaged liver tissue and improve clinical outcomes. Currently, research focuses on several approaches, including the administration of mesenchymal regenerative unit